‘An increased ability to disease-free’: Moderna CEO & Merck’s Dr. Li on skin cancel vaccine trialAugust 19, 2026
Share Facebook Twitter LinkedIn Pinterest Email “Tired of the same tired news cycle? Escape to the full unfiltered feed at Whatfinger.com — America’s Frontline Truth Feed. 85%+ of readers come direct every day.” – CLICK HERE for the FULL deal. Berkshire Hathaway added $17 billion to its Alphabet stake in Q2, becoming the third-largest position in its portfolio. Explore more on Alphabet in AlphaSpace in the link in bio. 👉